Liver Disease
📧 Sign up to get email alerts when something new happens for Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: RESTORE Declined Livers Study [NA]
Clinical trial update for the RESTORE Declined Livers Study; status is ACTIVE_NOT_RECRUITING with sponsor Washington University School of Me…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction [Phase 1, Phase 2]
A Phase 1/2 study evaluating the safety, tolerability, and pharmacodynamics of RTA 402 in patients with liver disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030) [Phase 1]
Phase 1 study of Enlicitide Decanoate in individuals with liver impairment and hepatic insufficiency has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders [NA]
This document reports completion of a clinical trial evaluating a culturally-based palliative care tele-consult program for rural Southern e…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections [NA]
A randomized prospective study comparing CUSA to radiofrequency ablation for liver resections has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease
The MELD ESAS Evolution study, evaluating the symptomatic burden in patients with advanced chronic liver disease, has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: The SHUNT-V Study for Varices [NA]
The SHUNT-V study for varices in chronic liver disease has completed, and results were posted on 2025-04-11. The sponsor is HepQuant, LLC.
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control Trial [NA]
A completed randomized controlled trial evaluating the effects of home-based aerobic and resistance training in individuals with chronic liv…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy
This ClinicalTrials.gov update reports that a study on chronic liver disease and radiation-induced second primary liver malignancy has compl…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases
A completed clinical trial evaluating the effect of direct-acting antiviral drugs on gut microbiota in patients with hepatitis C–related chr…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients
The completed study from Tanta University analyzed serum zinc and magnesium levels in patients with chronic liver disease and cirrhosis.
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Validation of the New Vibration-guided FibroScan Examination [NA]
This document reports the completion of a clinical trial validating a new vibration-guided FibroScan examination for assessing liver disease…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function [Phase 1]
A Phase 1 pharmacokinetic study in people with liver impairment to understand how Osivelotor is processed in the body. The trial status is c…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants [Phase 1]
Phase 1 study of Pirtobrutinib in healthy participants and those with hepatic impairment completed, with results posted; the data inform pha…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Effect of Exercise Based Regimen on Frailty in Children With Liver Disease [NA]
The ClinicalTrials.gov update confirms the study evaluating an exercise-based regimen to reduce frailty in children with liver disease has c…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function [Phase 1]
A Phase 1 pharmacokinetic study evaluating simufilam in subjects with hepatic impairment has been completed.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease [Phase 4]
A Phase 4 clinical trial evaluating DWJ1464 in patients with chronic liver disease has been completed.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients [NA]
A completed clinical trial evaluating a deep-learning model that combines clinical, biological, and ultrasound data to stratify hepatocarcin…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Achieving Portal Access With Scorpion Post-Approval Study (APASS) [NA]
Post-approval study APASS evaluating the Scorpion device for portal access in patients with portal hypertension and liver disease was termin…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure
A clinical trial evaluating avatrombopag for thrombocytopenia in adults with chronic liver disease undergoing a procedure was terminated.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study [Phase 2]
A Phase 2 proof-of-concept study evaluating repurposed sirolimus for compensated advanced chronic liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Influence of Microfiltered-seawater Supplementation and Variable Resistance Training in Blood Pressure, Oxidative Stress, Hepatic, and Renal Biomarkers in Older Women [NA]
Completed clinical trial evaluating whether microfiltered-seawater supplementation with resistance training affects blood pressure, oxidativ…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems [Phase 1]
A Phase 1 pharmacokinetic study assessing how BI 690517 is absorbed and processed in adults with liver impairment compared to healthy indivi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions [Phase 4]
Phase 4 study evaluating contrast-enhanced ultrasound vs MRI for differentiation of hepatic lesions has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes [NA]
Completed clinical trial evaluating health outcomes after alcohol cessation, with observations related to inflammation, neurocognition, live…